Skip to main content

Advertisement

SpringerLink
Log in

One year experience with erenumab: real-life data in 30 consecutive patients

  • BRIEF COMMUNICATION
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Deng H, Li GG, Nie H et al (2020) Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine - an updated systematic review and meta-analysis. BMC Neurol 20(1):57. https://doi.org/10.1186/s12883-020-01633-3-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ornello R, Casalena A, Frattale I et al (2020) Real-life data on the efficacy and safety of erenumab in the Abruzzo region, Central Italy. J Headache Pain 21(1):32. https://doi.org/10.1186/s10194-020-01102-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Russo A, Silvestro M, Scotto di Clemente F et al (2020) Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience. J Headache Pain 21(1):69. https://doi.org/10.1186/s10194-020-01143-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology and Stroke Unit - AORN “A. Cardarelli”, Via A. Cardarelli 9, 80131, Naples, Italy

    Angelo Ranieri, Gennaro Alfieri, Massimo Napolitano, Giovanna Servillo, Paolo Candelaresi, Walter Di Iorio, Katia Longo, Giorgia Teresa Maniscalco, Rosaria Renna, Mariana Rippa, Simona Salvatore, Anna Sagnelli, Ciro Florio & Valentino Manzo

  2. Headache Centre - Department of Neurology and Stroke Unit - AORN “A. Cardarelli”, Via A. Cardarelli 9, 80131, Naples, Italy

    Angelo Ranieri & Gennaro Alfieri

Authors
  1. Angelo Ranieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gennaro Alfieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Massimo Napolitano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giovanna Servillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paolo Candelaresi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Walter Di Iorio
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Katia Longo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Giorgia Teresa Maniscalco
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Rosaria Renna
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Mariana Rippa
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Simona Salvatore
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Anna Sagnelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Ciro Florio
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Valentino Manzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angelo Ranieri.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ranieri, A., Alfieri, G., Napolitano, M. et al. One year experience with erenumab: real-life data in 30 consecutive patients. Neurol Sci 41 (Suppl 2), 505–506 (2020). https://doi.org/10.1007/s10072-020-04677-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04677-y

Search

Navigation